Device-supported vs routine titration of insulin glargine 300 U/ml (Gla-300) in type 2 diabetes: efficacy and safety

被引：0
|
作者：
Flacke, F. [1 ]
Edelman, S. [2 ]
Bain, S. [3 ]
Hasslacher, C. [4 ]
Charpentier, G. [5 ]
Vespasiani, G. [6 ]
Goyeau, H. [7 ]
Woloschak, M. [8 ]
Davies, M. [9 ]
机构：
[1] Sanofi, Frankfurt, Germany
[2] Univ Calif San Diego, La Jolla, CA 92093 USA
[3] Swansea Univ, Inst Life Sci, Coll Med, Sch Med, Swansea, W Glam, Wales
[4] Diabet Inst Heidelberg, Heidelberg, Germany
[5] Sud Francilien Hosp, Dept Med, Corbeil Essonnes, France
[6] Ctr Outcomes Res & Clin Epidemiol, Pescara, Italy
[7] Sanofi, Chilly Mazarin, France
[8] Sanofi, New York, NY USA
[9] Univ Leicester, Univ Hosp Leicester, Diabet Res Ctr, Leicester, Leics, England
来源：
DIABETOLOGIA | 2017年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
674
引用
收藏
页码：S307 / S307
页数：1
相关论文
共 50 条
  • [21] Safety and Efficacy of Insulin Glargine 300 U/ml (Gla-300) Compared with Other Basal Insulin Therapies in Patients with Type 2 Diabetes Mellitus (T2DM)-A Network Meta-analysis (NMA)
    Wang, Hongwei
    Zhang, Quanwu
    Frois, Christian
    Vlajnic, Aleksandra
    Wu, Eric
    Gerrits, Charles
    Chou, Engels
    DIABETES, 2015, 64 : A26 - A26
  • [22] Gender differences in achieving glycaemic control in patients with type 2 diabetes initiated on insulin glargine 300 U/ml (Gla-300): the European REALI pooled database
    Bonnemaire, M.
    Bonadonna, R.
    Freemantle, N.
    Mauricio, D.
    Muller-Wieland, D.
    Bigot, G.
    Mauquois, C.
    Ciocca, A.
    Gourdy, P.
    DIABETOLOGIA, 2019, 62 : S439 - S439
  • [23] A CLINICALLY DEFINED NOCTURNAL WINDOW FOR ANALYSIS OF HYPOGLYCEMIA: NEW INSULIN GLARGINE 300U/ML (GLA-300) IN TYPE 2 DIABETES (T2DM)
    Riddle, M. C.
    Home, P. D.
    Avogaro, A.
    Gimenez Alvarez, M.
    Merino-Trigo, A.
    Grisoni, M. L.
    Glezer, S.
    Bolli, G. B.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2016, 18 : A45 - A46
  • [24] Efficacy and safety of insulin glargine 300 U/mL in people with type 2 diabetes in China: The INITIATION study
    Chen, Liming
    Wen, Binhong
    Liu, Haixia
    Wu, Hongmei
    Duan, Binhong
    Shu, Hongyan
    Zhang, Qiu
    Wu, Xiaohong
    Li, Min
    Han, Yanfang
    Kang, Lei
    Zhang, Minlu
    DIABETES OBESITY & METABOLISM, 2024,
  • [25] Glycaemic Control in People with Type 2 Diabetes Mellitus Switching from Basal Insulin to Insulin Glargine 300 U/ml (Gla-300): Results from the REALI Pooled Database
    Dirk Müller-Wieland
    Nick Freemantle
    Riccardo C. Bonadonna
    Celine Mauquoi
    Gregory Bigot
    Mireille Bonnemaire
    Pierre Gourdy
    Didac Mauricio
    Diabetes Therapy, 2023, 14 : 401 - 413
  • [26] Safety and Efficacy of Insulin Glargine 300 u/mL (Gla-300) Compared with Other Basal or Premixed Insulin Therapies in Patients with Type 2 Diabetes Mellitus (T2DM): A Network Meta-analysis (NMA)
    Freemantle, Nick
    Wang, Hongwei
    Thakur, Deepika
    Stella, Peter
    Chanan, Neha
    Kalra, Manik
    Guillermo, Jasso-Mosqueda Juan
    DIABETES, 2016, 65 : A566 - A566
  • [27] INSULIN GLARGINE 300 U/ML (GLA-300) VS 100 U/ML (GLA-100) IN PEOPLE ≥75 YEARS OLD WITH T2DM: SECONDARY ANALYSIS OF THE SENIOR STUDY
    Harris, S.
    Ritzel, R.
    Roussel, R.
    Baron, H.
    Florez, H.
    Espinasse, M.
    Muehlen-Bartmer, I.
    Zhang, N.
    Munshi, M.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2018, 20 : A136 - A136
  • [28] Glycaemic Control in People with Type 2 Diabetes Mellitus Switching from Basal Insulin to Insulin Glargine 300 U/ml (Gla-300): Results from the REALI Pooled Database
    Mueller-Wieland, Dirk
    Freemantle, Nick
    Bonadonna, Riccardo C.
    Mauquoi, Celine
    Bigot, Gregory
    Bonnemaire, Mireille
    Gourdy, Pierre
    Mauricio, Didac
    DIABETES THERAPY, 2023, 14 (02) : 401 - 413
  • [29] ONE-YEAR COST-UTILITY EVALUATION OF INSULIN GLARGINE 300U/ML (GLA-300) VERSUS INSULIN GLARGINE 100U/ML (GLA-100) IN PATIENTS WITH TYPE 2 DIABETES (T2DM) IN THAILAND
    Thongsri, W.
    Rattanawongsawad, S.
    Fournier, M.
    VALUE IN HEALTH, 2018, 21 : S39 - S39
  • [30] Plasma C-Peptide Concentration and Risk of Hypoglycemia in People with T2DM Treated with Insulin Glargine 300 U/mL (Gla-300) or Insulin Glargine 100 U/mL (Gla-100)
    Bolli, Geremia
    Ritzel, Robert
    Yale, Jean-Francois
    Escalada, Javier
    Davies, Melanie
    Landgraf, Wolfgang
    Bertolini, Monica
    Hecquet, Carole
    Yki-Jarvinen, Hannele
    Rosenstock, Julio
    DIABETES, 2017, 66 : A258 - A258
12345